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LETTERS TO THE EDITOR

Reply
TO THE EDITOR:
We appreciate the comments of Ikegami et al. with
regard to our recent study. Ikegami et al. pointed out
that the use of a left liver graft (LLG) in living donor
liver transplantation (LDLT) could be a good option
with portal flow modulation (PFM). First, there is
no doubt that donor safety should be prioritized in
LDLT.(1) Therefore, the use of an LLG should always
be taken into account during pretransplant evaluations. As Ikegami et al. described, the improvements
in surgical techniques and patient selection have successfully expanded the indications of LLGs in LDLT.
The importance of PFM has been well recognized for
successful post-LDLT outcomes.(2) Interestingly, the
Adult-to-Adult Living Donor Liver Transplantation
Cohort Study consortium reported their experience
with PFM in 2017, in which the benefits of PFM were
not clearly observed.(3) However, possible wide variability of the indications of PFM among centers might
mask its clinical impact. Therefore, we still agree that
appropriate PFM should improve post-LDLT outcomes in selected cases.
In our study, the risk of graft loss (GL) in LDLT
patients with ascites who received an LLG was higher
than either those who received right livers or those
without ascites who received LLGs.(4) Of note, the
Organ Procurement and Transplantation Network/
United Network for Organ Sharing registry does not
include detailed data on graft size/weight or PFM.
Therefore, we could not evaluate possible associations
between posttransplant outcomes and these aspects.
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The main message of our study was not necessarily
to warn the risk of LLG use, but to emphasize the
importance of standardized practice in challenging
LDLTs. Based on the findings of our study, excellent LDLT outcomes using an LLG reported from
experienced centers might not be reproduced nationwide.(3,4) Although higher utility of the LLG should
increase transplant opportunities and decrease the
risk of complications in living donors, our findings
may indicate that the use of an LLG requires sufficient expertise in the pretransplant decision-making
process and indications and techniques of PFM.
Recipient selection should also be carefully decided
because older age, moderate/severe ascites, or life
support requirements were found to be risk factors for
GL.(4) Although the use of an LLG has been increasing in the United States, center-level experience may
not be sufficient enough to achieve comparable outcomes to those receiving right liver graft in LDLT.
In terms of donor age and post-LDLT outcomes,
our results also showed that older donor age was an
independent risk factor for GL.(4) Receiving an LLG
from an older donor might amplify the risk of GL. The
use of an LLG should be determined judiciously, especially in older donors.
In summary, an LLG should be used with caution
especially in patients with ascites, older age and/or life
support requirements. Accumulating experience with
the use of LLGs would be important to standardize the
practice, including appropriate PFM, which should
lead to successful outcomes.
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